The WACC of Alnylam Pharmaceuticals Inc (ALNY) is 8.5%.
Range | Selected | |
Cost of equity | 7.40% - 9.80% | 8.60% |
Tax rate | 0.20% - 0.30% | 0.25% |
Cost of debt | 7.00% - 7.00% | 7.00% |
WACC | 7.3% - 9.7% | 8.5% |
Category | Low | High |
Long-term bond rate | 3.9% | 4.4% |
Equity market risk premium | 4.6% | 5.6% |
Adjusted beta | 0.76 | 0.88 |
Additional risk adjustments | 0.0% | 0.5% |
Cost of equity | 7.40% | 9.80% |
Tax rate | 0.20% | 0.30% |
Debt/Equity ratio | 0.03 | 0.03 |
Cost of debt | 7.00% | 7.00% |
After-tax WACC | 7.3% | 9.7% |
Selected WACC | 8.5% | |